Theranautilus, a deep-tech company developing nanorobotic solutions for healthcare, has raised $1.2 million in its seed funding round led by pi Ventures. The round also saw participation from Golden Sparrow Ventures and angel investors including Abhishek Goyal, Founder of Tracxn, and Lalit Keshre, Chief Executive Officer of Grow.
The funds raised will be used to commercialise nanorobotics-based medical devices globally, initially targeting dental care applications. Additionally, the funds will be utilised to develop Theranautilus’s go-to-market strategy and to advance its efforts in extending innovative technology beyond dental applications.
Talking about the funding, Shanmukh Srinivas, Co-founder, Theranautilus, said, “What sets our technology apart is its ability to address health challenges at a microscopic level with unprecedented precision. With this funding, we’re not just developing a product, we’re introducing a new paradigm in healthcare where nanorobots can navigate and perform different therapeutic and diagnostic procedures within the human body. Our initial focus on dental care represents the first step in what we envision as a revolution in medical treatment.”
Founded in 2020 at the Indian Institute of Science (IISc) by Professor Ambarish Ghosh, Debayan Dasgupta, and Peddi Shanmukh Srinivas, Theranautilus develops innovative nanorobotic solutions that address critical dental health challenges.
